Donald G Rau, MD in Nampa, ID - Radiology

Donald G Rau, MD is a Radiology - Diagnostic Radiology physician based in Nampa, Idaho. Donald G Rau is licensed to practice in Idaho (license number M3121) and his current practice location is 1512 12th Ave Rd, Nampa, Idaho. He can be reached at his office (for appointments etc.) via phone at (208) 463-5431.

NPI number for Donald G Rau is 1235260845 and his current mailing address is Po Box 9649, Boise, Idaho. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1235260845.

Contact Information

	Donald G Rau, MD
	1512 12th Ave Rd, Nampa, ID 83686-6008
	(208) 463-5431
	Not Available

Physician's Profile

Full Name	Donald G Rau
Gender	Male
Speciality	Radiology - Diagnostic Radiology
Location	1512 12th Ave Rd, Nampa, Idaho
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1235260845
Provider Enumeration Date: 03/07/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Donald G Rau such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1235260845	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2085R0202X	Radiology - Diagnostic Radiology	M3121 (Idaho)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Donald G Rau is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Donald G Rau, MD Po Box 9649, Boise, ID 83707-4649 Ph: (208) 472-8103	Donald G Rau, MD 1512 12th Ave Rd, Nampa, ID 83686-6008 Ph: (208) 463-5431

News Archive

Importance of the phosphatidylinositol 3 kinase (PI3K) pathway to breast cancer development

Because up to 75 percent of breast cancer patients have an abnormality in a specific cell signaling pathway, drugs that target different molecules along that pathway may be especially effective for treating the disease, says a researcher from The University of Texas M. D. Anderson Cancer Center.

Patients taking antidepressants for years likely to face dangerous withdrawal symptoms

Patients who have taken antidepressants for years should consider coming off the medication. However, researchers say they will likely face difficult and even dangerous withdrawal symptoms due to a physical dependence.

Remediable conditions influence health, development and growth of young children

Pediatric researchers from Boston Medical Center, in partnership with other Children's HealthWatch investigators in Minneapolis, Little Rock, Philadelphia, and Baltimore, have found that the cumulative effects of crowded and unstable housing and uncertain supplies of food and heat act together to decrease the chances of normal growth and development and good physical health among infants and toddlers.

65 per cent of Cree preschoolers in northern Quebec overweight or obese

Childhood obesity is increasing among the general population in Canada, but the statistics are even more alarming among First Nations, Inuit and Metis children.

Donald G Rau, MD - Radiology in Nampa, ID